Written by Derek Monson
September 15, 2020
The prescription drug market can seem like a complex web. It has multiple players and money is constantly moving. This visual describes where and how the money flows as prescription drugs travel from manufacturers to patients. You can also read the accompanying series here.
More Insights
Read More
Prescription Drug Q&A: The U.S. market and COVID vaccines
“The U.S. has a vibrant and thriving biopharma sector” – says American Enterprise Institute scholar and Milton Friedman chair James C. Capretta – “in large part because the payments system for these products is more favorable to the industry than it is elsewhere.”
Prescription Drug Q&A: The U.S. market-based system makes it a world leader in discovering new medicines
Americans get what they pay for when it comes to prescription drugs. We pay higher prices for drugs but gain access to nearly twice as many new medicines as citizens in foreign countries that use the law or government programs to set drug prices.
Q&A with legal scholar: Upcoming SCOTUS cases
With another U.S. Supreme Court term beginning, there are more opportunities for guidance and protection of religious freedom. To understand these opportunities, we asked Howard Slugh some questions about religious freedom cases in the upcoming court term.